|1||NCT01953588||Recruiting||Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery||
||Other / NIH||
||1455||Female||18 Years and older (Adult, Senior)||NCT01953588||A011106
|December 2013||April 2020||October 1, 2013||February 6, 2018||
|2||NCT01272037||Recruiting||Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer||
||10000||Female||18 Years and older (Adult, Senior)||NCT01272037||NCI-2011-02623
|January 15, 2011||February 1, 2022||January 7, 2011||February 15, 2018||
† Study has passed its completion date and status has not been verified in more than two years.